Global WholeHealth Partners Corp announced that SilverStream is an advanced wound-care solution designed to support the management of acute and chronic wounds, including post-surgical wounds, diabetic ulcers, venous ulcers, pressure ulcers, burns, cuts, and abrasions.
Public source
Publisher name
Public post
What happens when a post-surgical wound isn’t progressing? This documented SilverStream® case followed a 62-year-old patient with a non-healing post-surgical wound follo…
Company
Global WholeHealth Partners Corp
Pioneer of Rapid Diagnostic Test (RDT) & Real-time PCR Test, dedicated to distribute fast & accurate diagnostic testing.
- Industry
- Biotechnology Research
- Location
- San Clemente, US
- Company size
- 2–10 employees
About Global WholeHealth Partners Corp
Global WholeHealth Partners Corp. (GWHP), is a health organization that has a track record of pioneering two types of Invitro Diagnostic Point-of-Care tests: a) Rapid Diagnostic Test (RDT) b) Real-time PCR Test. Using GWHP innovative and advanced testing methods, they have accumulated a library of testing kits that is changing our world. GWHP's primary focus is directed towards the global fight against fatal vector borne diseases. These diseases include the above following: Ebola, ZIKA, Dengue Fever, Malaria, Influenza, Tuberculosis, and 200 Strands of Corona Viruses such as SARS, MERS (camel), Bovine (oxygen, cattle), Canine (dog) and Feline (cat). We're solving the problems related to current diagnostic testing such as: •Expensive to run •Difficult to use •Only test one strand of the disease •Inaccuracy / False negatives / High error latency •Increased deaths from delayed results of diagnoses •Tests take up to 72 hours and need a lab and refrigeration. GWHP's Solution •Rapid Diagnostic Test results delivered in 15 minutes with 98.9%-99.9% accuracy.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Products & Services
BUHLMANN Diagnostics Corp
BUHLMANN Diagnostics Corp released the fCAL® turbo calprotectin test, a non-invasive biomarker used for diagnosing IBD and differentiating IBD from IBS.
Products & Services
AccuBio Ltd
AccuBio Ltd launched VISITECT CD4 Advanced Disease to address the critical need to identify AHD and accelerate clinical decision making, providing a low cost, true in-field POC solution for community CD4 testing.
Products & Services
PHASE Scientific Americas
PHASE Scientific Americas released INDICAID Xylazine and Fentanyl Rapid Detection Tests designed to support harm reduction programs with simple workflows, built-in controls, and rapid, reliable results.
Products & Services
Seegene USA
Seegene USA announced the Novaplex GI-Helminth(I) Assay expands laboratory capabilities by targeting nine specific organisms including Enterocytozoon spp. / Encephalitozoon spp. (EN), Hymenolepis spp. (HY), Taenia spp. (TA), Enterobius vermicularis (EV), Strongyloides spp. (ST), Ascaris spp. (AS), Trichuris trichiura (TT), Ancylostoma spp. (AN), and Necator americanus (NA).
Products & Services
Vibrant Wellness